Previous close | 0.3000 |
Open | 0.0500 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 2.50 |
Expiry date | 2024-07-19 |
Day's range | 0.0500 - 0.3000 |
Contract range | N/A |
Volume | |
Open interest | 53 |
LOUISVILLE, Colo., May 28, 2024--Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company with a focus in lung disease, today announced Scott Hutton, Chief Executive Officer, will participate in two upcoming investor conferences:
LOUISVILLE, Colo., May 21, 2024--Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company with a focus in lung disease, announced that new data will be presented today at the 2024 American Thoracic Society (ATS) International Conference in San Diego, California. The presentation, titled "Performance comparison of a blood-based integrated classifier for lung nodule risk stratification in patients with versus without emphysema," will be presented by Arthur Romero MD, MSC, FCCP, Associ
A week ago, Biodesix, Inc. ( NASDAQ:BDSX ) came out with a strong set of quarterly numbers that could potentially lead...